Am. Oliveira et al., p27(kip1) protein expression correlates with survival in myxoid and round-cell liposarcoma, J CL ONCOL, 18(15), 2000, pp. 2888-2893
Purpose: The p27(kip1) protein (p27) is a cyclin-dependent kinase inhibitor
that has been shown to be an independent prognostic factor in a variety of
human neoplasms. Low expression of p27 tends to occur in more aggressive n
eoplasms. The role of p27 as an independent prognostic factor in the spectr
um of myxoid and round-cell liposarcomas has not been examined.
Materials and Methods: Forty-seven cases of myxoid and round-cell liposarco
mas were examined. Clinicopathologic features and immunohistochemical expre
ssion of p27 and Ki-67 antigen were studied in all cases. Survival analysis
was performed using the log-rank test and the Cox multivariate regression
model.
Results: The male:female ratio was 1.4:1, and the mean age at diagnosis was
45 years. The tumors were located in the lower extremities (94%) and retro
peritoneum (6%). The median tumor sire war 13.5 cm. The median follow-up wa
s 6.3 years, and the overall 5- and 10-year survival rates were 76% and 67%
, respectively. Low expression of p27 was identified in 34 cases (72%) and
correlated with decreased metastasis-free (P = .026) and overall survival (
P = .008). In a multivariate analysis, only round-cell differentiation and
low expression of p27 independently predicted decreased metastasis-free and
overall survival.
Conclusion: p27 expression predicts the clinical behavior of myxoid and rou
nd-cell liposarcomas, even in neoplasms with few or no round-cell different
iation. J Clin Oncol 18:2888-2893. (C) 2000 by American Society of Clinical
Oncology.